LHCSX Mutual Fund
LHCSX Mutual Fund
LHCSX Mutual Fund
Lord Abbett Health Care Fund Class R4
LHCSX Mutual Fund Overview
LHCSX Mutual Fund (Lord Abbett Health Care Fund Class R4) is managed by Lord Abbett Family of Funds. LHCSX expense ratio is 1.03%, holding 64 positions across sectors including Health Care, Financials, Industrials. Inception date: 2019-07-31.
LHCSX performance shows a YTD return of 3.29%. The 1-year return is 28.65% and the 5-year return is 3.56%. LHCSX dividend yield stands at 0.16%, paid annually.
LHCSX top holdings include Eli Lilly & Co. (8.9%), AstraZeneca PLC (4.7%), Gilead Sciences (4.3%), Johnson & Johnson - Common (3.2%), Nektar Therapeutics (3.2%). Go to all LHCSX holdings, LHCSX sectors, or LHCSX dividends.
LHCSX can be compared against other funds. Use LHCSX overlap to find shared positions, or LHCSX vs another fund for a side-by-side view. LHCSX alternatives are available via the screener, along with tax-loss harvesting opportunities.